About us

세로바

CEO

Ph.D. CEO
KWANG-SUNG AHN

Disease prognostic Minner
CEO of PDXen Biosystems Co.

  • MAJOR IN Oncology Biology and Oncology Genetics
  • Ph.D. (University of Houston)
  • Post-doc (UCLA)
  • Senior Researcher (Samsung Biomedical Research Institute, SBRI)
  • Research Professor of Pathology, Korea University College of Medicine
  • Research Professor, Cancer Research Institute, Seoul National University College of Medicine

Organization

History

2019

01　Registration of Animal laboratory Facilities

2018

11　Establishment of Seoul Branch
11　Registration of PDXen Institutional Review Board (IRB)
07　Investment attraction from Individual Investors
04　Selected as Korea Engineering Service Provider (K-ESP)
01　Established of Pangyo Branch in Pangyo 2nd Techno Valley Enterprise Support Hub Center

2017

11　Registered as a Research Institute of ETRI (No. 500)
10　Moved the head office to ETRI Convergence Technology Commercialization Center
10　Investment attraction from ETRI and ETRI Holdings Co
09　Certification of Research and Development Services

2015

09　Moved the head office to Venture Town of Korea Institute of Science and Technology

2014

01　Establishment of Research Institute (Functional Genome Institute)

2013

10　Certified as a Venture Company
09　Establishment of PDXen Biosystems Co.